Aberrant regulation of choline metabolism by mitochondrial electron transport system inhibition in neuroblastoma cells

Metabolomics

Volumn 4, Issue 4, 2008, Pages 347-356

  Baykal, Ahmet T ^a   Jain, Mohit R ^a   Li, Hong ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Metabolomics; Mitochondrial disease; NMR; Pattern recognition; SH SY5Y

Indexed keywords

EID: 55349126716     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-008-0125-3     Document Type: Article

References (37)

1. Aboagye, E. O., & Bhujwalla, Z. M. (1999). Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Research, 59, 80-84.
2. Barker, P. B., Glickson, J. D., & Bryan, R. N. (1993). In vivo magnetic resonance spectroscopy of human brain tumors. Topics in Magnetic Resonance Imaging, 5, 32-45. doi: 10.1097/ 00002142-199300520-00006.
3. Beal, M. F. (1998). Mitochondrial dysfunction in neurodegenerative diseases. Biochimica et Biophysica Acta, 1366, 211-223. doi: 10.1016/ S0005-2728(98)00114-5.
4. Beal, M. F., Brouillet, E., Jenkins, B. G., Ferrante, R. J., Kowall, N. W., Miller, J. M., et al. (1993). Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. The Journal of Neuroscience, 13, 4181-4192.
5. Bove, J., Prou, D., Perier, C., & Przedborski, S. (2005). Toxin-induced models of Parkinson's disease. Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics, 2, 484-494.
6. Brouillet, E., Conde, F., Beal, M. F., & Hantraye, P. (1999). Replicating Huntington's disease phenotype in experimental animals. Progress in Neurobiology, 59, 427-468. doi: 10.1016/ S0301-0082(99)00005-2.
7. Browne, S. E., Bowling, A. C., MacGarvey, U., Baik, M. J., Berger, S. C., Muqit, M. M., et al. (1997). Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia. Annals of Neurology, 41, 646-653. doi: 10.1002/ ana.410410514.
8. Choi, S. Y., Huang, P., Jenkins, G. M., Chan, D. C., Schiller, J., & Frohman, M. A. (2006). A common lipid links Mfn-mediated mitochondrial fusion and SNARE-regulated exocytosis. Nature Cell Biology, 8, 1255-1262. doi: 10.1038/ncb1487.
9. Clarke, C. E., & Lowry, M. (2000). Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy. European Journal of Neurology, 7, 661-665. doi: 10.1046/j.1468-1331.2000.00111.x.
10. Farber, S. A., Slack, B. E., & Blusztajn, J. K. (2000). Acceleration of phosphatidylcholine synthesis and breakdown by inhibitors of mitochondrial function in neuronal cells: A model of the membrane defect of Alzheimer's disease. The FASEB Journal, 14, 2198-2206. doi: 10.1096/ fj.99-0853.
11. Farooqui, A. A., Horrocks, L. A., & Farooqui, T. (2000). Glycerophospholipids in brain: Their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chemistry and Physics of Lipids, 106, 1-29. doi: 10.1016/ S0009-3084(00)00128-6.
12. Glunde, K., Jacobs, M. A., & Bhujwalla, Z. M. (2006). Choline metabolism in cancer: Implications for diagnosis and therapy. Expert Review of Molecular Diagnostics, 6, 821-829. doi: 10.1586/ 14737159.6.6.821.
13. Glunde, K., Shah, T., Winnard, P. T., Jr., Raman, V., Takagi, T., Vesuna, F., et al. (2008). Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1 alpha signaling in a human prostate cancer model. Cancer Research, 68, 172-180. doi: 10.1158/ 0008-5472.CAN-07-2678.
14. Govindaraju, V., Young, K., & Maudsley, A. A. (2000). Proton NMR chemical shifts and coupling constants for brain metabolites. NMR in Biomedicine, 13, 129-153. doi: 10.1002/ 1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V.
15. Jenkins, B. G., Choi, J.-K., & Beal, M. F. (2005). Magnetic resonance spectroscopy of neurodegenerative illness. In M. F. Beal, A. E. Lang & A. Ludolph (Eds.), Neurodegenerative Diseases. London: Cambridge University Press.
16. 1H NMR spectroscopy. Neurology, 43, 2689-2695.
17. Kanthasamy, A. G., Borowitz, J. L., Pavlakovic, G., & Isom, G. E. (1994). Dopaminergic neurotoxicity of cyanide: Neurochemical, histological, and behavioral characterization. Toxicology and Applied Pharmacology, 126, 156-163. doi: 10.1006/taap.1994.1102.
18. Kinsey, G. R., McHowat, J., Beckett, C. S., & Schnellmann, R. G. (2007). Identification of calcium-independent phospholipase A2gamma in mitochondria and its role in mitochondrial oxidative stress. American Journal of Physiology. Renal Physiology, 292, F853-F860. doi: 10.1152/ ajprenal.00318.2006.
19. Li, Z., & Vance, D. E. (2008). Phosphatidylcholine and choline homeostasis. Jornal of Lipid Research, 48, 1187-1194.
20. MacKay, S., Ezekiel, F., Di Sclafani, V., Meyerhoff, D. J., Gerson, J., Norman, D., et al. (1996). Alzheimer disease and subcortical ischemic vascular dementia: Evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging. Radiology, 198, 537-545.
21. Meyerhoff, D. J., MacKay, S., Constans, J. M., Norman, D., Van Dyke, C., Fein, G., et al. (1994). Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Annals of Neurology, 36, 40-47. doi: 10.1002/ ana.410360110.
22. Michel, V., Yuan, Z., Ramsubir, S., & Bakovic, M. (2006). Choline transport for phospholipid synthesis. Experimental Biology and Medicine (Maywood, NJ), 231, 490-504.
23. Negendank, W. (1992). Studies of human tumors by MRS: A review. NMR in Biomedicine, 5, 303-324.
24. Ohta, S., & Ohsawa, I. (2006). Dysfunction of mitochondria and oxidative stress in the pathogenesis of Alzheimer's disease: On defects in the cytochrome c oxidase complex and aldehyde detoxification. Journal of Alzheimer's Disease, 9, 155-166.
25. Oude Weernink, P. A., López de Jesús, M., & Schmidt, M. (2007). Phospholipase D signaling: Orchestration by PIP2 and small GTPases. Naunyn-Schmiedeberg's Archives of Pharmacology, 374, 399-411. doi: 10.1007/s00210-007-0131-4.
26. 1 H NMR-based metabolomics indicates a neurotransmitter cycling deficit in cerebral tissue from a mouse model of Batten disease. The Journal of Biological Chemistry, 280, 42508-42514. doi: 10.1074/jbc.M507380200.
27. Podo, F. (1999). Tumour phospholipid metabolism. NMR in Biomedicine, 12, 413-439. doi: 10.1002/ (SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U.
28. Schapira, A. H., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989). Mitochondrial complex I deficiency in Parkinson's disease. Lancet, 1, 1269. doi: 10.1016/S0140-6736(89)92366-0.
29. Schmidt, N., & Ferger, B. (2001). Neurochemical findings in the MPTP model of Parkinson's disease. Journal of Neural Transmission, 108, 1263-1282. doi: 10.1007/s007020100004.
30. Sharpley, M. S., Shannon, R. J., Draghi, F., & Hirst, J. (2006). Interactions between phospholipids and NADH:uBiquinone oxidoreductase (complex I) from bovine mitochondria. Biochemistry, 45, 241-248. doi: 10.1021/bi051809x.
31. Sherer, T. B., Betarbet, R., Stout, A. K., Lund, S., Baptista, M., Panov, A. V., et al. (2002). An in vitro model of Parkinson's disease: Linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. The Journal of Neuroscience, 22, 7006-7015.
32. Steinhour, E., Sherwani, S. I., Mazerik, J. N., Ciapala, V., O'Connor Butler, E., Cruff, J. P., et al. (2008) Redox-active antioxidant modulation of lipid signaling in vascular endothelial cells: Vitamin C induces activation of phospholipase D through phospholipase A(2), lipoxygenase, and cyclooxygenase. Molecular and Cellular Biochemistry, 315, 97-112.
33. Tetrud, J. W., & Langston, J. W. (1989). MPTP-induced parkinsonism as a model for Parkinson's disease. Acta Neurologica Scandinavica. Supplementum, 126, 35-40.
34. van Meer, G., Voelker, D. R., & Feigenson, G. W. (2008). Membrane lipids: Where they are and how they behave. Nature Reviews. Molecular Cell Biology, 9, 112-124. doi: 10.1038/nrm2330.
35. Wolf, R. A., & Gross, R. W. (1985). Identification of neutral active phospholipase C which hydrolyzes choline glycerophospholipids and plasmalogen selective phospholipase A2 in canine myocardium. The Journal of Biological Chemistry, 260, 7295-7303.
36. Zeisel, S. H., & Blusztajn, J. K. (1994). Choline and human nutrition. Annual Review of Nutrition, 14, 269-296. doi: 10.1146/ annurev.nu.14.070194.001413.
37. Zhu, D., Lai, Y., Shelat, P. B., Hu, C., Sun, G. Y., & Lee, J. C. (2006). Phospholipases A2 mediate amyloid-beta peptide-induced mitochondrial dysfunction. The Journal of Neuroscience, 26, 11111-11119. doi: 10.1523/JNEUROSCI.3505-06.2006.